Alistair R W Williams Selected Research

Dinoprost

9/2009	Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha.
11/2005	A positive feedback loop that regulates cyclooxygenase-2 expression and prostaglandin F2alpha synthesis via the F-series-prostanoid receptor and extracellular signal-regulated kinase 1/2 signaling pathway.
9/2005	A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas.
2/2004	Expression, localization, and signaling of prostaglandin F2 alpha receptor in human endometrial adenocarcinoma: regulation of proliferation by activation of the epidermal growth factor receptor and mitogen-activated protein kinase signaling pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alistair R W Williams Research Topics

Disease

9	Adenocarcinoma 01/2010 - 02/2004
8	Neoplasms (Cancer) 01/2018 - 12/2004
6	Leiomyoma (Uterine Fibroids) 01/2017 - 12/2008
5	Hemorrhage 09/2020 - 08/2006
5	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 03/2007
4	Hyperplasia 01/2018 - 11/2003
3	Carcinogenesis 11/2005 - 02/2004
2	Infections 01/2019 - 04/2007
2	Disease Progression 01/2019 - 06/2007
2	Endometriosis 08/2014 - 05/2008
2	Ovarian Epithelial Carcinoma 12/2011 - 06/2007
1	Menorrhagia 01/2021
1	Hypersensitivity (Allergy) 01/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Uterine Cervical Dysplasia 04/2018
1	Endometrial Hyperplasia 01/2017
1	Polyps 11/2012
1	Myoma 11/2012
1	Ectopic Pregnancy 12/2009
1	Endometrial Neoplasms (Endometrial Cancer) 09/2009
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2008
1	Amenorrhea 04/2007
1	Anovulation 04/2007
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 04/2007
1	Tuberous Sclerosis 2 12/2004
1	Carcinosarcoma 05/2004

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2004
7	Messenger RNA (mRNA)IBA 01/2010 - 09/2005
7	ProstaglandinsIBA 01/2010 - 12/2004
6	prostaglandin F2alpha receptorIBA 01/2010 - 02/2004
5	Progesterone Receptors (Progesterone Receptor)IBA 09/2013 - 05/2008
4	ulipristal acetate FDA Link 01/2021 - 11/2012
4	PlatinumIBA 01/2019 - 05/2004
4	Biomarkers (Surrogate Marker)IBA 04/2018 - 12/2011
4	DinoprostIBA 09/2009 - 02/2004
4	Estrogens (Estrogen)FDA Link 09/2007 - 11/2003
3	EnzymesIBA 06/2018 - 09/2009
3	Progesterone FDA LinkGeneric 08/2014 - 11/2003
3	Prostaglandins FIBA 12/2009 - 02/2004
3	Letrozole (Femara)FDA LinkGeneric 09/2007 - 03/2007
3	Estrogen ReceptorsIBA 09/2007 - 03/2007
3	Aromatase InhibitorsIBA 09/2007 - 03/2007
2	Progestins (Progestagens)IBA 09/2020 - 04/2007
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2014 - 11/2012
2	asoprisnilIBA 09/2013 - 12/2008
2	CalcineurinIBA 01/2010 - 12/2009
2	CalciumIBA 01/2010 - 12/2009
2	Steroid Receptors (Steroid Receptor)IBA 12/2009 - 04/2007
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2009 - 08/2007
2	Indicators and Reagents (Reagents)IBA 09/2007 - 03/2007
2	ParaffinIBA 09/2007 - 03/2007
2	Mifepristone (RU 486)FDA Link 04/2007 - 11/2003
1	Immunoglobulin G (IgG)IBA 01/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2019
1	Poly Adenosine Diphosphate RiboseIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 06/2018
1	Metformin (Glucophage)FDA LinkGeneric 06/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2018
1	Oxamic AcidIBA 06/2018
1	Cisplatin (Platino)FDA LinkGeneric 06/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Biological ProductsIBA 01/2017
1	SteroidsIBA 08/2014
1	Postcoital Contraceptives (Morning After Pill)IBA 08/2014
1	cetrorelix (Cetrotide)FDA Link 01/2014
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2014
1	Goserelin (Zoladex)FDA Link 01/2014
1	Interleukin-15 (Interleukin 15)IBA 09/2013
1	BRCA1 ProteinIBA 12/2011
1	taxaneIBA 12/2011
1	Interleukin-11 (Interleukin 11)IBA 01/2010
1	ImmunosorbentsIBA 01/2010
1	Protein Isoforms (Isoforms)IBA 01/2010
1	CXC ChemokinesIBA 12/2009
1	LigandsIBA 12/2009
1	Protein Kinase CIBA 12/2009
1	Estrogen Receptor betaIBA 09/2009
1	Estrogen Receptor alphaIBA 09/2009
1	Interleukin-8B ReceptorsIBA 07/2009
1	Chemokine CXCL1IBA 07/2009
1	Aromatase (CYP19)IBA 09/2007
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 08/2007
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 08/2007
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 08/2007
1	Estrogen Receptor Modulators (Antiestrogen)IBA 06/2007
1	Contraceptive Agents (Contraceptives)IBA 04/2007
1	Insulin-Like Growth Factor Binding ProteinsIBA 03/2007
1	Insulin-Like PeptidesIBA 03/2007
1	Complementary DNA (cDNA)IBA 11/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2005
1	Dinoprostone (PGE2)FDA Link 12/2004
1	Tuberous Sclerosis Complex 2 ProteinIBA 12/2004
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2004
1	Mitogen-Activated Protein KinasesIBA 02/2004
1	Type C PhospholipasesIBA 02/2004

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 01/2019 - 05/2004
3	Therapeutics 09/2007 - 03/2007
2	Aftercare (After-Treatment) 09/2020 - 11/2012
2	Hysterectomy 01/2014 - 12/2008
1	Duration of Therapy 04/2007